Head-to-head · WeighScore
Nirwana Health vs Omada Health
The verdict
Nirwana Health takes it — 66.4/100 to 55.6/100.
Nirwana Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nirwana Health (nirwanahealth.com) is a telehealth service offering compounded GLP-1 weight loss plus hair, sexual-wellness, and longevity care through licensed providers.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Nirwana Health | Omada Health |
|---|---|---|
| WeighScore | 66.4/100 | 55.6/100 |
| Grade | C | C |
| Scorecard rank | #191 | #436 |
| Semaglutide | $149/mo (compounded) | Not disclosed |
| Tirzepatide | $229/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #191 · C
Strengths
- Offers compounded semaglutide and tirzepatide as both weekly injections and oral tablets
- Transparent, published pricing with month-to-month, quarterly, and 6-month plans and no membership fee
- Multi-month plans cut the per-month cost sharply (semaglutide as low as $99/mo, tirzepatide as low as $133/mo)
- Advertises a $50-off code (LOOSE50) and covers weight loss plus hair, sexual-wellness, and longevity care
- Also lists a retatrutide option and custom dosing plans for higher needs
Where it loses points
- Prescribing medical group and compounding pharmacy are not named on the site
- States of operation are not published; confirm eligibility during intake
- Says it is 'LegitScript certified' but no verifiable seal is shown, so the claim is unconfirmed
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #436 · C
Strengths
- Added GLP-1 prescribing and medication management in late 2025
- Clinicians trained in obesity care, available in all 50 states
- Behavioral support wrapped before, during and after treatment
- GLP-1 Flex Care adds a cash-pay medication pathway in 2026
- Publicly traded, evidence-based virtual care platform
Where it loses points
- Core program distributed via employers and health plans, limited cash-pay
- GLP-1 prescribing is a recent addition still scaling
- GLP-1 Flex Care only rolling out to employers later in 2026
- No transparent published price for the core member program
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.